NEUROCRINE BIOSCIENCES INC (NBIX)

Latest Insider Confidence Score

2026Q1

51.3
Bullish

Company insider confidence (by quarter)

2016Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Neurocrine Biosciences Inc 10% Owner 8,575,316 Feb 24, 2023
Coughlin Timothy CFO 137,961 Feb 8, 2017
Gorman Kevin Charles Director 106,322 Aug 11, 2025
Nevinny Corinne H Director 43,283 May 9, 2018
Lloyd-Smith Malcolm Chief Integration Officer 42,337 Feb 8, 2023

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 4, 2026 Mar 5, 2026 ABERNETHY MATT CFO Neutral 27.5 -2,249 -4.99% ✗ -
Feb 20, 2026 Feb 23, 2026 Onyia Jude Chief Scientific Officer Neutral 27.5 -3,110 -10.81% ✗ -
Feb 12, 2026 Feb 17, 2026 ABERNETHY MATT CFO Sell 70.0 +844 0.40% ✗ $1.1M
Feb 12, 2026 Feb 17, 2026 Boyer David W. Chief Corp. Affairs Officer Sell 90.0 +1,916 4.24% ✗ $998.5K
Feb 12, 2026 Feb 17, 2026 Gano Kyle CEO Sell 42.5 -653 -0.09% ✗ $1.3M
Feb 12, 2026 Feb 17, 2026 Onyia Jude Chief Scientific Officer Sell 92.5 +4,836 4.08% ✗ $1.9M
Feb 12, 2026 Feb 17, 2026 BENEVICH ERIC Chief Commercial Officer Sell 87.5 +4,386 1.49% ✗ $1.5M
Feb 12, 2026 Feb 17, 2026 Cooke Julie Chief Human Resources Officer Sell 85.0 +2,270 1.44% ✗ $954.7K
Feb 12, 2026 Feb 17, 2026 Lippoldt Darin Chief Legal Officer Sell 70.0 +1,045 0.33% ✗ $1.1M
Feb 12, 2026 Feb 17, 2026 Delaet Ingrid Chief Regulatory Officer Sell 100.0 +6,809 12.24% ✗ $1.6M
Feb 13, 2026 Feb 17, 2026 GORMAN KEVIN CHARLES Director Sell 88.8 +23,419 1.09% ✗ $5M
Feb 13, 2026 Feb 17, 2026 Keswani Sanjay Chandru Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 31, 2026 Feb 3, 2026 Boyer David W. Chief Corp. Affairs Officer Sell 42.5 -1,189 -20.15% ✗ $161.8K
Jan 31, 2026 Feb 3, 2026 BENEVICH ERIC Chief Commercial Officer Sell 42.5 -1,292 -2.39% ✗ $175.8K
Jan 31, 2026 Feb 3, 2026 ABERNETHY MATT CFO Sell 42.5 -1,368 -3.56% ✗ $186.1K
Jan 31, 2026 Feb 3, 2026 Cooke Julie Chief Human Resources Officer Sell 42.5 -997 -3.49% ✗ $135.7K
Jan 31, 2026 Feb 3, 2026 Delaet Ingrid Chief Regulatory Officer Sell 42.5 -475 -8.59% ✗ $64.6K
Jan 31, 2026 Feb 3, 2026 Gano Kyle CEO Sell 42.5 -1,580 -1.10% ✗ $215K
Jan 31, 2026 Feb 3, 2026 GORMAN KEVIN CHARLES Director Sell 42.5 -2,845 -0.55% ✗ $387.1K
Jan 31, 2026 Feb 3, 2026 Lippoldt Darin Chief Legal Officer Sell 42.5 -1,335 -2.72% ✗ $181.6K
Jan 31, 2026 Feb 3, 2026 Onyia Jude Chief Scientific Officer Sell 48.8 -142 -0.88% ✗ $19.3K
Jan 16, 2026 Jan 20, 2026 Gano Kyle CEO Sell 23.8 -36,400 -11.47% ✓ $4.8M
Nov 28, 2025 Jan 16, 2026 BENEVICH ERIC Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jan 8, 2026 Jan 12, 2026 Lippoldt Darin Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Dec 15, 2025 Dec 17, 2025 Norwalk Leslie V Director Sell 7.5 -6,190 -49.80% ✓ $945.7K
Dec 8, 2025 Dec 10, 2025 Lippoldt Darin Chief Legal Officer Sell 26.3 -4,376 -9.16% ✓ $698.6K
Dec 3, 2025 Dec 4, 2025 LYONS GARY A Director Sell 20.0 -15,000 -11.07% ✓ $2.3M
Nov 28, 2025 Dec 2, 2025 BENEVICH ERIC Chief Commercial Officer Sell 22.5 -5,970 -11.74% ✓ $905.9K
Nov 29, 2025 Dec 2, 2025 Onyia Jude Chief Scientific Officer Sell 40.0 -2,248 -12.40% ✗ $342.1K
Nov 25, 2025 Nov 26, 2025 MORROW GEORGE J Director Sell 5.0 -15,000 -67.97% ✓ $2.2M
Nov 5, 2025 Nov 6, 2025 RASTETTER WILLIAM H Director Sell 5.0 -18,000 -30.84% ✓ $2.7M
Nov 1, 2025 Nov 4, 2025 Gano Kyle CEO Sell 53.8 -300 -0.21% ✓ $42.6K
Sep 3, 2025 Sep 4, 2025 Onyia Jude Chief Scientific Officer Neutral 27.5 -1,470 -9.69% ✗ -
Sep 2, 2025 Sep 3, 2025 SHERWIN STEPHEN A Director Neutral 27.5 -1,000 -7.38% ✗ -
Aug 7, 2025 Aug 11, 2025 GORMAN KEVIN CHARLES Director Sell 12.5 -106,322 -17.12% ✓ $13.4M
Aug 5, 2025 Aug 7, 2025 Onyia Jude Chief Scientific Officer Neutral 27.5 -3,116 -17.04% ✗ -
Jul 10, 2025 Jul 11, 2025 Delaet Ingrid Chief Regulatory Officer Sell 28.8 -457 -8.81% ✓ $61.7K
Jul 9, 2025 Jul 11, 2025 Onyia Jude Chief Scientific Officer Sell 3.8 -59,819 -76.58% ✓ $7.8M
Jul 2, 2025 Jul 7, 2025 Onyia Jude Chief Scientific Officer Sell 5.0 -20,362 -52.68% ✓ $2.6M
Jun 2, 2025 Jun 4, 2025 Keswani Sanjay Chandru Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jun 4, 2025 Keswani Sanjay Chandru Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
May 27, 2025 May 29, 2025 GORMAN KEVIN CHARLES Director Sell 40.0 -9,613 -1.83% ✓ $1.2M
May 22, 2025 May 22, 2025 RASTETTER WILLIAM H Director Neutral 52.5 - 0.00% ✗ -
May 22, 2025 May 22, 2025 POON CHRISTINE A Director Neutral 52.5 - 0.00% ✗ -
May 21, 2025 May 22, 2025 GORMAN KEVIN CHARLES Director Neutral 52.5 - 0.00% ✗ -
May 22, 2025 May 22, 2025 Sharp Shalini Director Neutral 52.5 - 0.00% ✗ -
May 22, 2025 May 22, 2025 SHERWIN STEPHEN A Director Neutral 52.5 - 0.00% ✗ -
May 22, 2025 May 22, 2025 POPS RICHARD F Director Neutral 52.5 - 0.00% ✗ -
May 22, 2025 May 22, 2025 MORROW GEORGE J Director Neutral 52.5 - 0.00% ✗ -
May 22, 2025 May 22, 2025 LYONS GARY A Director Neutral 52.5 - 0.00% ✗ -
May 22, 2025 May 22, 2025 Norwalk Leslie V Director Neutral 52.5 - 0.00% ✗ -
May 22, 2025 May 22, 2025 Mercier Johanna Director Neutral 52.5 - 0.00% ✗ -
May 16, 2025 May 20, 2025 Cooke Julie Chief Human Resources Officer Neutral 52.5 - 0.00% ✗ -
May 5, 2025 May 7, 2025 RASTETTER WILLIAM H Director Sell 5.0 -30,000 -44.45% ✓ $3.3M
Feb 13, 2025 Feb 14, 2025 Cooke Julie Chief Human Resources Officer Sell 37.5 -1,551 -3.76% ✓ $181.1K
Feb 13, 2025 Feb 14, 2025 GORMAN KEVIN CHARLES Director Sell 45.0 -5,844 -0.56% ✓ $681.9K
Feb 13, 2025 Feb 14, 2025 SHERWIN STEPHEN A Director Sell 5.0 -13,831 -56.44% ✓ $1.6M
Feb 13, 2025 Feb 14, 2025 ROBERTS EIRY Chief Medical Officer Sell 38.8 -2,218 -2.08% ✓ $258.3K
Feb 13, 2025 Feb 14, 2025 Onyia Jude Chief Scientific Officer Sell 26.3 -2,879 -7.61% ✓ $336.2K
Feb 12, 2025 Feb 14, 2025 Lippoldt Darin Chief Legal Officer Sell 42.5 -2,374 -1.83% ✓ $255K
Feb 13, 2025 Feb 14, 2025 Gano Kyle CEO Sell 45.0 -2,558 -0.91% ✓ $298.9K
Feb 13, 2025 Feb 14, 2025 Delaet Ingrid Chief Regulatory Officer Sell 25.0 -1,471 -14.30% ✓ $171.7K
Feb 13, 2025 Feb 14, 2025 Boyer David W. Chief Corp. Affairs Officer Sell 15.0 -1,785 -21.76% ✓ $208.4K
Feb 13, 2025 Feb 14, 2025 BENEVICH ERIC Chief Commercial Officer Sell 38.8 -2,154 -2.38% ✓ $251.4K
Feb 13, 2025 Feb 14, 2025 ABERNETHY MATT CFO Sell 35.0 -2,558 -3.50% ✓ $298.9K
Feb 8, 2025 Feb 12, 2025 Cooke Julie Chief Human Resources Officer Sell 37.5 -700 -3.58% ✓ $82.8K
Feb 8, 2025 Feb 12, 2025 GORMAN KEVIN CHARLES Director Sell 46.3 -2,274 -0.44% ✓ $269.2K
Feb 8, 2025 Feb 12, 2025 ROBERTS EIRY Chief Medical Officer Sell 41.3 -980 -2.86% ✓ $115.9K
Feb 8, 2025 Feb 12, 2025 Lippoldt Darin Chief Legal Officer Sell 41.3 -911 -2.14% ✓ $107.7K
Feb 8, 2025 Feb 12, 2025 Gano Kyle CEO Sell 47.5 -980 -0.71% ✓ $116K
Feb 8, 2025 Feb 12, 2025 Boyer David W. Chief Corp. Affairs Officer Sell 10.0 -700 -25.95% ✓ $82.8K
Feb 8, 2025 Feb 12, 2025 BENEVICH ERIC Chief Commercial Officer Sell 41.3 -980 -2.24% ✓ $115.9K
Feb 8, 2025 Feb 12, 2025 ABERNETHY MATT CFO Sell 41.3 -980 -2.84% ✓ $115.9K
Jan 31, 2025 Feb 4, 2025 Cooke Julie Chief Human Resources Officer Sell 26.3 -1,740 -8.73% ✓ $266K
Jan 31, 2025 Feb 4, 2025 GORMAN KEVIN CHARLES Director Sell 45.0 -2,707 -0.52% ✓ $414K
Jan 31, 2025 Feb 4, 2025 ROBERTS EIRY Chief Medical Officer Sell 37.5 -1,457 -4.31% ✓ $222.6K
Jan 31, 2025 Feb 4, 2025 Onyia Jude Chief Scientific Officer Sell 51.3 -126 -0.80% ✓ $19.3K
Jan 31, 2025 Feb 4, 2025 Lippoldt Darin Chief Legal Officer Sell 41.3 -1,250 -2.97% ✓ $191.1K
Jan 31, 2025 Feb 4, 2025 Gano Kyle CEO Sell 45.0 -1,541 -1.11% ✓ $235.6K
Jan 31, 2025 Feb 4, 2025 Delaet Ingrid Chief Regulatory Officer Sell 25.0 -1,045 -14.17% ✓ $157.6K
Jan 31, 2025 Feb 4, 2025 Boyer David W. Chief Corp. Affairs Officer Sell 10.0 -1,104 -44.64% ✓ $168.8K
Jan 31, 2025 Feb 4, 2025 BENEVICH ERIC Chief Commercial Officer Sell 41.3 -1,207 -2.80% ✓ $184.6K
Jan 31, 2025 Feb 4, 2025 ABERNETHY MATT CFO Sell 37.5 -1,283 -3.78% ✓ $196.1K
Jan 27, 2025 Jan 29, 2025 GORMAN KEVIN CHARLES Director Sell 7.5 -146,105 -22.11% ✓ $21.8M
Jan 15, 2025 Jan 17, 2025 Gano Kyle CEO Sell 13.8 -65,000 -19.36% ✓ $9.2M
Dec 31, 2024 Jan 3, 2025 Delaet Ingrid Chief Regulatory Officer Sell 32.5 -272 -9.79% ✓ $37.6K
Dec 17, 2024 Dec 19, 2024 ROBERTS EIRY Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 17, 2024 Dec 19, 2024 Delaet Ingrid Chief Regulatory Officer Sell 10.0 -1,091 -30.32% ✓ $147.3K
Nov 29, 2024 Dec 3, 2024 Onyia Jude Chief Scientific Officer Sell 22.5 -2,331 -13.11% ✓ $294.4K
Nov 8, 2024 Nov 12, 2024 ROBERTS EIRY Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Nov 4, 2024 Nov 7, 2024 SHERWIN STEPHEN A Director Neutral 27.5 -2,000 -7.55% ✗ -
Nov 1, 2024 Nov 1, 2024 Gano Kyle CEO Neutral 52.5 - 0.00% ✗ -
Oct 3, 2024 Oct 7, 2024 Boyer David W. Chief Corp. Affairs Officer Sell 10.0 -1,295 -77.45% ✓ $147.2K
Sep 13, 2024 Sep 17, 2024 Boyer David W. Chief Corp. Affairs Officer Sell 7.5 -3,461 -67.43% ✓ $421.8K
Aug 15, 2024 Aug 16, 2024 RASTETTER WILLIAM H Director Sell 17.5 -14,250 -27.54% ✗ $2.1M
Aug 13, 2024 Aug 15, 2024 LYONS GARY A Director Sell 23.8 -11,570 -8.86% ✓ $1.7M
Aug 13, 2024 Aug 15, 2024 ABERNETHY MATT CFO Sell 5.0 -14,100 -30.90% ✓ $2.1M
Aug 13, 2024 Aug 15, 2024 Delaet Ingrid Chief Regulatory Officer Sell 5.0 -7,143 -74.02% ✓ $1.1M
Aug 6, 2024 Aug 8, 2024 Delaet Ingrid Chief Regulatory Officer Sell 41.3 -273 -3.97% ✓ $40.3K
Aug 1, 2024 Aug 5, 2024 Cooke Julie Chief Human Resources Officer Sell 5.0 -12,632 -40.97% ✓ $1.9M